Provider approved by the California Board of Registered Nursing, CEP# 13791
Nurses will receive 1.00 contact hours for participating in this course.
Relias, LLC is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Nurses will receive 1.00 contact hours for participating in this course.
DC-RN -- District of Columbia Board of Nursing Approved Continuing Education program (CE Provider #50-290).
Nurses will receive 1.00 contact hours for participating in this course.
Florida Board of Nursing CE Provider #: 50-290
Nurses will receive 1.00 contact hours for participating in this course.
Georgia Board of Nursing CE Provider #: 50-290
Nurses will receive 1.00 contact hours for participating in this course.
This program was approved by the South Carolina Board of Nursing Approved Continuing Education Program (CE provider #50-290) CE Broker Course # 20-[Custom_Code]
Relias LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Relias LLC designates this enduring material activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Outline:
Speed Dating with Drugs
PharmasOnly.com
Objectives
Disclosure
Risky (Opioid) Business
Helpful Resources to Share
Vitamin H
An Itch you can’t scratch: Gabapentin in liver failure
Let It Go?! Calcium and Vitamin D
Pumping Iron
That’s Atypical…Long term bisphosphonates-> Fx?!
ACP Osteoporosis Guidelines Updated
Going STEADI
Scraped Knees and Boo Boos
Speaking of cows…
Pair Off…
11 animals in 1 minute
Metformin – New Cutoffs for Use
I’ll take combo #3 – trouble in River City
Hypoglycemia – How low can you go?
Hypoglycemia – How low can you go?
Kratom – So sad, too bad…You’re BUSTED!
Changing role of beta-blockers in cirrhosis
What was the first BILLION-DOLLAR drug?
Cimetidine (Tagamet)
STOP! Before you stop that medication!
Codeine – World-Class Stinker! Tramadol too!
DEA mandates reduction in opioid manufacturing
Preventing Urinary Tract Infections
OK, how about some D-mannose?
OK, how about some D-mannose?
The Disimpactor
Emergency visits
For relief of fecal impaction
Goodnight, sleep tight
Medications Inducing Insomnia
Sleep aid to the rescue?!
Grapefruits and Friends
Grapefruit ok with statins?!
Other Juicy Tidbits
New COPD GOLD Guidelines
Spirometrically confirmed diagnosis
Drug Therapy Algorithms
Here’s how we do it in Hospicetown…
Palliative Care is GOLDen for COPD Patients
Good as GOLD?!
NOAC’s
Medical Cannabis Use in Older Adults
How do you solve a problem like Maria?
Opioid Stewardship Interventions
Patient opioid-naïve
Patient opioid-naïve and in a pain crisis
Patient opioid-tolerant, but can swallow, uncontrolled pain
Patient already receiving parenteral morphine
Patient already receiving parenteral morphine
Patient cannot swallow tablets, buccal route not feasible
More on intensols
Even MORE about intensols!
Say what?
Benzodiazepines and opioids – no, no bad dog!
BZD and Opioid Overdose Deaths
Gabapentin and Opioids
Tell me true – are we buying what they’re selling?
Who would like to recoup the cost of this trip?
Pseudobulbar Affect – Who’s up for Nuedexta?
Can we duplicate this and save some $$??
Speed Dating with the Pharmacy Ladies: PharmasOnly.com
Kathryn Anne Walker, PharmD, BCPS, CPE is the Senior Clinical and Scientific Director for Palliative Care for MedStar Health System. She is charged with developing clinical outcomes, research and education along with developing the palliative clinical services at the ten hospitals and in the outpatient community of MedStar Health. She also serves as an Associate Professor at the University of Maryland School of Pharmacy where she contributes to both didactic and experiential pharmacy education. She has served as principle investigator on several grants and co-investigator on an NIH/NINR R01 grant to validate a pain assessment tool for non-communicative patients. Dr. Walker has been an invited speaker both nationally and internationally at professional conferences and disseminated her work through posters, paper sessions and peer reviewed journal articles. She has served as a research mentor for over ten years to medical students from University of Maryland School of Pharmacy and Medicine and Georgetown University. After her Doctor of Pharmacy degree at Duquesne University Dr. Walker completed the only specialty residency at the time in palliative care at University of Maryland School of pharmacy. She is also a board certified pharmacotherapy specialist and certified pain educator. Dr. Walker's passion for safe and appropriate medication use includes a major focus on relief of suffering and drives her efforts in clinical practice, research and education. Disclosure: Kathryn A. Walker, Pharm.D., BCPS, CPE has declared that no conflict of interest, Relevant Financial Relationship or Relevant Non-Financial Relationship exists.Instructor: Mary Lynn McPherson, Pharm.D., MA, MDE, BCPS, CPE
Mary Lynn McPherson, Pharm.D., MA, MDE, BCPS, CPE, is Professor and Executive Director, Advanced Post-Graduate Education in Palliative Care in the Department of Pharmacy Practice and Science at the University of Maryland School of Pharmacy in Baltimore. Dr. McPherson has a Master's degree in Instructional Systems Development, and a Masters in Distance Education and e-Learning. Dr. McPherson has maintained a practice in both hospice (local and national) and ambulatory care her entire career. Dr. McPherson teaches extensively in the Doctor of Pharmacy curriculum on pain management and end of life care, including didactic and experiential content. She is the Program Director of the Online Master of Science and Graduate Certificates in Palliative Care at the University of Maryland, Baltimore. She also developed one of the first and few palliative care pharmacy residencies in the U.S. Dr. McPherson has won numerous awards for teaching, and her innovative practice in end of life care. She has published numerous articles, chapters, and four books including the best-selling "Demystifying Opioid Conversion Calculations: A Guide for Effective Dosing." Disclosure: Mary Lynn McPherson, Pharm.D., MA, MDE, BCPS, CPE has declared that no conflict of interest, Relevant Financial Relationship or Relevant Non-Financial Relationship exists.